Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Arthritis & Rheumatology (Hoboken, N.J.)|December 30, 2017
Hypomethylation of CYP2E1 and DUSP22 Promoters Associated With Disease Activity and Erosive Disease Among Rheumatoid Arthritis PatientsAmanda Mok, Brooke Rhead, Calliope Holingue, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 30, 2023
Identification of Cell-Specific Differential DNA Methylation Associated With Methotrexate Treatment Response in Rheumatoid ArthritisCameron Adams, Nisha Nair, Darren Plant, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 4, 2021
Activated Peripheral Blood B Cells in Rheumatoid Arthritis and Their Relationship to Anti-Tumor Necrosis Factor Treatment and Response: A Randomized Clinical Trial of the Effects of Anti-Tumor Necrosis Factor on B CellsNida Meednu, Jennifer Barnard, Kelly Callahan, et al.
Medrxiv : the Preprint Server for Health Sciences|February 27, 2026
Longitudinal peripheral blood multi-omic profiling in seropositive individuals identifies immune endotypes and predictive models for future rheumatoid arthritis conversionJun Inamo, Aleksandra Bylinska, Miles Smith, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 30, 2025
A phase 2 trial of hydroxychloroquine in individuals at risk for rheumatoid arthritisKevin D Deane, Christopher C Striebich, Marie L Feser, et al.
Annals of Internal Medicine|August 30, 2021
Effect of Immunosuppression on the Immunogenicity of mRNA Vaccines to SARS-CoV-2 : A Prospective Cohort StudyParakkal Deepak, Wooseob Kim, Michael A Paley, et al.
Medrxiv : the Preprint Server for Health Sciences|April 14, 2021
Glucocorticoids and B Cell Depleting Agents Substantially Impair Immunogenicity of mRNA Vaccines to SARS-CoV-2Parakkal Deepak, Wooseob Kim, Michael A Paley, et al.
Pageof 4